Search Results

From Cambridge to Leadership That early curiosity led her to pursue a PhD in Molecular Pharmacology at

β-receptor partial agonists, showing how heart rate set-points under different anesthetics can flip observed pharmacology Subscribe today and get direct access to decades of pharmacology experience that turn complex systems Why Terry’s Corner Most pharmacology training freezes at equilibrium snapshots.

If your work touches GPCR pharmacology, these insights aren’t optional—they’re essential. Career opportunities:  Senior/Principal Scientist—GPCR Pharmacology; Principal Scientist—In Vitro Pharmacology Terry’s Corner: GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures Discovery collapses

community by expanding access to validated, industry-standard GPCR assay platforms that enable rigorous pharmacological accelerate GPCR-targeted drug discovery by connecting scientists with proven assay platforms, deep pharmacological are trusted by leading pharmaceutical companies worldwide to generate high-quality, decision-enabling pharmacological

Each week we highlight the decisions that move GPCR projects forward—from pharmacology essentials to Years of chemistry, photophysics, and pharmacology condensed into one breakthrough: pHSense , a reagent They translated a fundamental principle of chemistry into a usable platform for pharmacology—showing

Schild analysis turns receptor pharmacology into detective work, spotlighting mechanistic fingerprints Modern pharmacology has powerful modeling software, yet Schild analysis remains the litmus test for mechanism Watch the course trailer 👇 Why Terry’s Corner Weekly pharmacology lectures by Dr.

GPCR internalization isn’t just a trafficking readout—it’s pharmacology. s partnership with Durham (chemistry) and the Institute of Functional Genomics in Montpellier (GPCR pharmacology

research position in GPCR biochemistry and biophysics and a research associate/scientist in in vitro pharmacology “The best pharmacology teacher (Dr. Also super-valuable for those of us learning how to teach pharmacology” — Dr.

Pharmacological chaperones are cell-permeant small molecules that engage nascent mutant GPCRs in the Therefore, CAN1404 acts as a pharmacological chaperone and can rescue cell surface expression and function effects of genetic mutations on GPCR function and provide a proof of therapeutic principle for FSHR pharmacological

members — Susanna Naggie, MD, and Sudarshan Rajagopal, MD, PhD — have been elected to the American Society Naggie and Rajagopal are two of 95 new members elected to the society for 2022.

GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between Health and Disease GPCRs arguably represent the most effective current therapeutic targets for a plethora of diseases. GPCRs also possess a pivotal role in the regulation of the physiological balance between healthy and pathological conditions; thus, their importance in systems biology cannot be underestimated. The molecular diversity of GPCR signaling systems is likely to be closely associated with disease-associated changes in organismal tissue complexity and compartmentalization, thus enabling a nuanced GPCR-based capacity to interdict multiple disease pathomechanisms at a systemic level. GPCRs have been long considered as controllers of communication between tissues and cells. This communication involves the ligand-mediated control of cell surface receptors that then direct their stimuli to impact cell physiology. Given the tremendous success of GPCRs as therapeutic targets, considerable focus has been placed on the ability of these therapeutics to modulate diseases by acting at cell surface receptors. In the past decade, however, attention has focused upon how stable multiprotein GPCR superstructures, termed receptorsomes, both at the cell surface membrane and in the intracellular domain dictate and condition long-term GPCR activities associated with the regulation of protein expression patterns, cellular stress responses and DNA integrity management. The ability of these receptorsomes (often in the absence of typical cell surface ligands) to control complex cellular activities implicates them as key controllers of the functional balance between health and disease. A greater understanding of this function of GPCRs is likely to significantly augment our ability to further employ these proteins in a multitude of diseases. Read full article

Early Access and Updates    Terry’s Corner is launching soon with monthly courses, AMAs, and real-world pharmacology

Pharmacological Reviews   2025 , 77  (6), 100092. https://doi.org/10.1016/j.pharmr.2025.100092 . (2) British J Pharmacology 2022, 179 (14), 3496–3511. https://doi.org/10.1111/bph.15103 . (5) Borrmann, T Pharmacol. 2000, 362, 382-391. https://doi.org/10.1007/s002100000315 (7) Jacobson, K. A. J., Eds.; Handbook of Experimental Pharmacology; Springer Berlin Heidelberg: Berlin, Heidelberg, 2009 Biochemical Pharmacology   1973 , 22  (23), 3099–3108. https://doi.org/10.1016/0006-2952(73)90196-2 .

Proteins Professor Andrew Hopkins, Exscientia’s founder and CEO, was elected as a Fellow of the The Royal Society Financial Results and Recent Highlights OMass Therapeutics presented at the 23rd BioEquity Conference British Participants Diagnosed with WHIM Syndrome GPCR Events, Meetings, and Webinars ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics (May 18 - 21, 2023). (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023).

Terry’s Pharmacology Corner is built around that reality. continuous learning environment — supporting scientific reasoning as programs mature, rather than treating pharmacology Why Terry’s Pharmacology Corner Mechanistic understanding evolves. Terry’s Pharmacology Corner provides a structured environment for that evolution: Weekly advanced pharmacology Forty years of pharmacological expertise — organized into a year-round learning framework for serious

the chemical matter  interacting with that target lacks the right properties to produce meaningful pharmacology In this lesson, you’ll gain: A strategic view of how chemical scaffolds shape pharmacologic outcomes Building on Known Pharmacology Medicinal chemists learned early that modifying endogenous molecules — It was early structure-based pharmacology. Dr. They are mainstream pharmacology.

Allosteric GPCR Binding Sites and Their Ligandability Potential Today, we started the Principles of Pharmacology Emerging Voices in GPCR Biology in Special Issue of Molecular Pharmacology GPCR Events, Meetings, and GPCRs-Targeted Drug Discovery Summit Europe July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology GPCR Jobs Scientist I Cell Biology - Tectonic Therapeutic Senior Scientist, GPCR Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser Group Postdoctoral

Graeme Milligan for receiving the Order of British Empire from King Charles III in recognition of his Graeme Milligan was awarded the Order of British Empire by King Charles III for services to Biochemical Postdoctoral Fellow, Caron Lab NEW Clinical Trial Associate Research Scientist/Senior Scientist I - Molecular Pharmacology President, Medical Affairs Associate Director / Director, Clinical Operations Professor in Cardiovascular Pharmacology

Thrilling beginning to Principles of Pharmacology I We are excited to announce the start of our Principles of Pharmacology I course! Don’t miss this opportunity to advance your knowledge and skills in pharmacology! Modules: October 31st : The Eyes to See- The Importance of Pharmacologic Assays. Emerging Voices in GPCR Biology in Special Issue of Molecular Pharmacology GPCR Events, Meetings, and

The Importance of Binding in Drug Action In pharmacology, binding must happen before any drug effect potency, but this isn't always the case due to various biological factors. 📚 Whether you're new to pharmacology You'll gain valuable insights into the critical role binding plays in pharmacology. Understanding the intricate details of drug-receptor interactions transforms how we approach pharmacology

Terry walks you through real-world experiments, decades of receptor pharmacology wisdom, and the cutting-edge 🔓 Find the lesson in Terry’s Pharmacology Vault: “Efficacy and System Sensitivity Unlock "Agonism &

🚨 Hurry to reserve your spot for the Principles of Pharmacology I & II BUNDLE before the Early Every Thursday at 10 AM EST: Principles of Pharmacology I Dates: October 3, 10, 17, 24 (four sessions ) Topics: Pharmacologic activity measurement, mechanisms of action, and GPCR discovery strategies. Registration deadline: September 27, 2024 Principles of Pharmacology II Dates: October 31, November Emerging Voices in GPCR Biology in Special Issue of Molecular Pharmacology GPCR Events, Meetings, and

If you're just beginning your pharmacology journey… This is the lesson that will connect the dots. You’ll leave with the language, logic, and big-picture view that underpins all future learning in pharmacology

Gunnar Schulte for his study on the International Union of Basic and Clinical Pharmacology. Jianming Han, Tao Che for their analysis of GPCR-G protein selectivity revealed by structural pharmacology Here’s a sneak peek at what you can expect: Principles of Pharmacology in Drug Discovery I - Techniques Principles of Pharmacology in Drug Discovery II - Advanced Methods for the Optimization of Candidate 2026 GPCR Jobs HIGHLIGHT Principal Scientist, In vitro pharmacology NEW Senior Scientist - Discovery

I We are diving into the second class of our Principles of Pharmacology I course with enthusiasm and you missed out on enrolling in this one, worry not – a spot is reserved just for you in Principles of Pharmacology Seize this opportunity to enhance your expertise and proficiency in pharmacology! Modules: October 31st : The Eyes to See- The Importance of Pharmacologic Assays. Emerging Voices in GPCR Biology in Special Issue of Molecular Pharmacology GPCR Events, Meetings, and

This new learning hub is your go-to space to revisit core pharmacology concepts, master new ones, and Explore Terry's Corner Better decisions start with better pharmacology.

Don't miss out on this chance to elevate your knowledge and skills in pharmacology! Apply unique pharmacologic assays and unconventional ligands to unveil GPCR activities. Emerging Voices in GPCR Biology in Special Issue of Molecular Pharmacology GPCR Events, Meetings, and GPCR Jobs HIGHLIGHT Senior Scientist, GPCR Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser Group Postdoctoral Scholar – iPSC in cardiac and endothelial

Course Schedule and Details Every Thursday at 10 am EST Principles of Pharmacology in Drug Discovery Candidate Molecules Dates: September 5th to 26th, 2024 Overview: This course delves into the essential pharmacologic Principles of Pharmacology in Drug Discovery II - Advanced Methods for the Optimization of Candidate , 2024 | 11th Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology Director GPCR Drug Discovery Biologist Post-Doctoral Scientist- Molecular Pharmacology (FDE) Join Dr.

Pharmacology isn’t only about ligands, receptors, and downstream G protein signaling—it’s also about The Hidden Lever in GPCR Research In GPCR pharmacology, the conversation often centers on ligand properties—affinity Clarify whether observed effects reflect true pharmacology or assay artifacts . From Bench Insight to Strategic Advantage Terry Kenakin’s decades of pharmacology leadership converge A growing on-demand library  of expert pharmacology lessons to revisit anytime.

the latest GPCR research, including breakthrough studies, upcoming events, and our newly announced pharmacology pharmacologic activity measurement, mechanisms of action, and GPCR discovery strategies. Principles of Pharmacology II October 31, November 7, 14, 21, December 5 (five sessions) (we skipped The Principles of Pharmacology I & II BUNDLE is your golden ticket to mastering the field. Secure your spot today and elevate your pharmacology expertise!